Cargando…
BCOR-CCNB3 sarcoma with concurrent RNF213-SLC26A11 gene fusion: a rare sarcoma with altered histopathological features after chemotherapy
BACKGROUND: Chemotherapy is a common approach for cancer treatment, but intrinsic genetic mutations in different individuals may cause different responses to chemotherapy, resulting in unique histopathological changes. The genetic mutation along with the distinct histopathological features may indic...
Autores principales: | Huang, Wen, Wang, Wei, Huang, Liang-Liang, Li, Heng, Zhou, Wen-Chao, Wu, Hai-Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9107253/ https://www.ncbi.nlm.nih.gov/pubmed/35568949 http://dx.doi.org/10.1186/s12957-022-02611-4 |
Ejemplares similares
-
BCOR-CCNB3 Fusions Are Frequent in Undifferentiated Sarcomas of Male Children
por: Peters, Tricia L., et al.
Publicado: (2014) -
Rare Case of BCOR::CCNB3 Sarcoma of Bone
por: Arai, Yumi, et al.
Publicado: (2023) -
BCOR-CCNB3 sarcoma arising in the proximal tibia: A case report
por: Suzuki, Kayo, et al.
Publicado: (2022) -
A Rare Case of Lower Limb Sarcoma With BCOR-CCNB3 Mutation: Diagnosis and Treatment
por: Kedia, Ansh, et al.
Publicado: (2023) -
Sustained Complete Response to Palbociclib in a Refractory Pediatric Sarcoma With BCOR-CCNB3 Fusion and Germline CDKN2B Variant
por: Tramontana, Timothy F., et al.
Publicado: (2020)